Physician

John Marshall Strong, M.D.

According to 2025 Medicare claims, John Strong, M.D. (NPI: 1043248719) practices family practice in the El Centro, CA market, with the plurality of this provider's patient population coming from Imperial, CA. This provider's primary affiliated billing organization is LEGACY MD MEDICAL GROUP INC (NPI: 1073210753; TIN: 88-4410340) and primary practice location at 92243-4241. Strong is affiliated with the Asaar Medical Inc. (ACO ID: D0071), participating under the REACH model.

Strong's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,429 traditional Medicare patients, billed 13,555 HCPCS/CPT codes, and received $577,745 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 14,615 prescription claims across 1,549 beneficiaries totaling $1,455,189 in drug costs, led by Ozempic (Semaglutide). DME data shows 221 claims. Open Payments data shows 23 records totaling $889. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,663 to $577,745. Similarly, Part D prescription costs have risen steadily, from $49,210 to $1,455,189. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,233 and ending at $13,650.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	41	60	$2,663
2016	34	53	$2,957
2017	110	203	$10,831
2018	664	1,935	$100,352
2019	590	2,152	$120,421
2020	795	2,895	$150,658
2021	1,612	4,414	$244,735
2022	1,640	6,656	$279,365
2023	1,318	6,013	$320,736
2024	1,429	13,555	$577,745

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	141	838	$49,210
2016	78	390	$15,946
2017	348	1,717	$105,858
2018	680	4,433	$426,496
2019	819	6,490	$561,261
2020	1,076	9,088	$794,066
2021	1,219	10,332	$1,026,413
2022	1,230	10,827	$957,558
2023	1,409	11,697	$1,031,657
2024	1,549	14,615	$1,455,189

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	47	$722
2016	N/R	N/R	N/R
2017	N/R	26	$385
2018	N/R	74	$927
2019	N/R	35	$689
2020	19	73	$2,579
2021	35	154	$3,952
2022	45	142	$2,932
2023	58	179	$4,946
2024	61	221	$14,894

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	608	1,043	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,137	3,890	$66
87811	Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)	245	310	$41
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	240	240	$19
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	445	656	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	134	4,230	$123,195
Trulicity	Dulaglutide	94	3,200	$103,422
Farxiga	Dapagliflozin Propanediol	120	5,170	$92,211
Jardiance	Empagliflozin	76	3,550	$63,962
Linzess	Linaclotide	83	3,030	$53,833

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	23	$7,878
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	12	$3,763
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	15	$1,051
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	43	88	$929
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	11	$539

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$889	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Marshall Strong, M.D.?

Tedicare shows public-source Medicare data for John Marshall Strong, M.D. (NPI 1043248719), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Marshall Strong, M.D. have ACO affiliation data?

John Marshall Strong, M.D. is shown with ACO affiliation data for Asaar Medical Inc. (REACH, ACO ID D0071).

What billing organization is linked to John Marshall Strong, M.D.?

John Marshall Strong, M.D. is linked to LEGACY MD MEDICAL GROUP INC (billing NPI 1073210753) in the available physician profile data.

Does John Marshall Strong, M.D. have Open Payments data?

John Marshall Strong, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.